Cemiplimab trials for Stage IV Lung Cancer AJCC v8

All Cemiplimab trials · All Stage IV Lung Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Cemiplimab for Stage IV Lung Cancer AJCC v8

• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
  NCT06616584 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 386 locations
• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
  NCT06731270 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
  NCT05501665 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Cemiplimab for Stage IV Lung Cancer AJCC v8?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.